Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck

JOURNAL ARTICLE published 27 August 2018 in Frontiers in Oncology

Authors: Tomohiro Enokida | Susumu Okano | Takao Fujisawa | Yuri Ueda | Shinya Uozumi | Makoto Tahara